Correlation Between CEUS Identification of Nodular HPD on CE-MRI and Hepatic Malignant Lesions

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Feb 4, 2025

Keywords

ClinConnect Summary

Hepatic malignant tumors, including hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and liver metastases, represent a significant global health burden due to their high incidence and mortality rates. With advancements in imaging techniques, the detection of hepatic perfusion disorders (HPD) in high-risk populations during screening and follow-up has increased. However, the imaging characteristics of HPD lack distinct heterogeneity, and certain benign lesions-such as post-treatment inflammatory reactions, arterioportal shunts, hyperplastic nodules, focal fat deposition...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Prospective cohort patients voluntarily sign the informed consent form.
• • Patients with a history of malignant tumors, CE-MRI indicated the presence of HPD in the liver.
• • The shape of HPD is nodular.
• • The diameter of HPD is greater than 10mm.
• • The main large vessels in the liver are clearly displayed in the MRI.
• Exclusion Criteria:
• • Patients who unable to complete imaging examinations, such as severe cardiac insufficiency, severe renal insufficiency, hypersensitivity to contrast agents or adverse reactions to them, etc.
• • Patients with the history of extensive liver resection or liver transplantation.
• • Patients whose abdomen with abundant intestinal gas.